Forte Biosciences, Inc.
USD51.50
+4.01 (+8.44%)
CEO
Paul A. Wagner
IPO Date
2017-04-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$49.88
Prev. Close
$47.49
Day Low
$49.26
Day High
$52.67
52W Low
$9.10
52W High
$52.67
Market Cap
$0.72B
Volume
0.54M
| 134 |
| $21.32 |
| 6 Jul 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | M-Exempt | Disposed | 375 | $0.00 |
| 6 Jul 2026 | Wagner Paul A. | director, officer: SEE REMARKS | M-Exempt | Acquired | 1,250 | $0.00 |
| 6 Jul 2026 | Wagner Paul A. | director, officer: SEE REMARKS | F-InKind | Disposed | 98 | $21.32 |
| 6 Jul 2026 | Wagner Paul A. | director, officer: SEE REMARKS | M-Exempt | Disposed | 1,250 | $0.00 |
| 17 Jun 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | A-Award | Acquired | 22,000 | $17.15 |
| 17 Jun 2026 | Wagner Paul A. | director, officer: SEE REMARKS | A-Award | Acquired | 500,000 | $17.15 |
| 2 Jun 2026 | Doberstein Stephen K | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Kapoor Shivpreet Singh | director | A-Award | Acquired | 18,353 | $0.00 |